Drug Manufacturers and Pharmacist Groups Champion Their “Dual Value”
A coalition of drug manufacturers and pharmacies will begin testing a public relations message on the "dual value" of prescription drugs and community pharmacists this fall
You may also be interested in...
Medication therapy management programs mandated under the Medicare Modernization Act provide "the single greatest opportunity for pharmacy in over 30 years," Kerr Drugs Exec VP-Pharmacy & Logistics Ralph Petri said
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials